GoPro (GPRO) announces review of strategic alternatives
Newsquawk Staff ·
GoPro (GPRO) announces review of strategic alternatives.
What it means
GoPro's announcement of a review of strategic alternatives indicates a proactive approach to enhancing shareholder value, potentially leading to various corporate actions such as a sale, merger, or partnership. Investors should consider the implications of this move in terms of valuation prospects and market positioning, as it could attract interest from potential acquirers or alter competitive dynamics in the action camera space.
- Tesla (TSLA) has decided not to proceed with plans to produce Cybertruck for Australia and New Zealand
- OpenAI trims valuation target to USD 1.25tln after previously pitching a higher price, according to FT
- Newmont (NEM) says production growth is expected to begin in 2027 following previously flagged 2026 trough, adds Q3 gold production was broadly flat sequentially as anticipated
- SpaceX (SPCX) in talks to access 80,000 cell sites for new network
- Google (GOOG) announces general availability of an Anthropic-managed deployment option for Claude models on Google Cloud
Related headlines
- OpenAI is raising up to USD 30bln in funding round at a USD 1.25tln valuation, led by UAE investors, according to CNBC, citing sources; OpenAI is negotiating a commercial deal that would secure more computing capacity from the UAE4 hours ago
- Gilead Sciences (GILD) entered into a definitive agreement to acquire an oral IL-23R inhibitor program, including lead asset HCXT-2001, from PepStar Therapeutics Limited; deal valued at USD 1.27bln in upfront cash4 hours ago
- Newmont (NEM) Q3 2026 (USD): Adj. EPS 2.20 (exp. 2.06), Revenue 6.36bln (exp. 6.30bln), Adj. EBITDA 3.95bln (exp. 3.73bln)4 hours ago
- Bloom Energy (BE) Q3 2026 (USD): Adj. EPS 0.94 (exp. 0.69), Revenue 1.24bln (exp. 1.06bln)4 hours ago
- Western Digital (WDC) Q1 2027 (USD): Adj. EPS 4.64 (exp. 4.08), Revenue 4.38bln (exp. 4.14bln)4 hours ago
- Merck & Co (MRK) and Moderna (MRNA) say safety profile of Intismeran plus Keytruda was generally consistent with previously reported studies of combination; significantly reduced the risk of recurrence or death by 42% compared to Keytruda alone6 hours ago
- DataDog (DDOG) recently offered almost USD 4bln to acquire Upwind Security, but the Co. hasn't accepted the offer, reports The Information citing sources7 hours ago
- Statnews posts on X, "Rumors are swirling that the Treasury Department this week is going to propose a rule that restricts U.S. investment in the Chinese biotech sector"7 hours ago
- Moderna (MRNA) downside attributed to early data leaks (link below) - UNCONFIRMED8 hours ago
- State of Rhode Island sues Meta (META) over alleged tolerance for scam advertising8 hours ago
- Uber (UBER) puts all 30,000 employees on ChatGPT Work8 hours ago
- Elon Musk makes USD 1bln investment in Skydance (SKYD), Semafor reports8 hours ago
- Newsquawk Daily US Earnings Estimates - 23rd October 2026: AXP8 hours ago
- Nvidia (NVDA) launches Minerva platform for end-to-end AI factory observability9 hours ago
- SpaceX's (SPCX) SpaceXSI names Bain, Nvidia (NVDA) and Snowflake (SNOW) as launch partners10 hours ago